Business
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, and Cleveland-Cliffs and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Inve...
About this update from Go Metals Corp.
[{"type":"text","content":"Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, and Cleveland-Cliffs and Encourages Investors to Contact the Firm\n\n\n\n\n Bragar Eagel & Squire, P.C.\n \n\n Litigation Partner\n \n\n\n Brandon Walker\n \n\n\n Encourages Investors Who Suffered Losses In\n \n\n\n Semler\n \n\n\n (SMLR),\n \n\n\n GoHealth\n \n\n\n (GOCO), or\n \n\n\n Cleveland-Cliffs\n \n\n\n (CLF) To Contact Him Directly To Discuss Their Options\n \n\n\n\n If you purchased or acquired securities in Semler, GoHealth, or Cleveland-Cliffs between [class period] and would like to discuss your legal rights, call Bragar Eagel & Squire partner\n \n\n\n Brandon Walker\n \n\n\n or\n \n\n\n Marion Passmore\n \n\n\n directly at (212) 355-4648.\n \n\n\n NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) --\n \n Bragar Eagel & Squire, P.C\n \n ., a nationally recognized shareholder rights law firm, is investigating potential claims against GoHealth, Inc. (NASDAQ:GOCO), Semler Scientific Inc. (NASDAQ:SMLR), and Cleveland-Cliffs Inc. (NYSE:CLF). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.\n \n\n\n Semler Scientific Inc. (NASDAQ:SMLR)\n \n\n\n On February 28, 2025, Semler filed its Form 10-K with the SEC and therein, disclosed that the Company received an initial civil investigative demand from the U.S. Department of Justice (\"DOJ\") in July 2017 regarding Semler's claims for reimbursement related to its QuantaFlo device. Semler received subsequent requests for information in February 2019, December 2021, April 2022, and April 2023. In February 2025, Semler participated in settlement discussions with the DOJ, which were unsuccessful. The Company disclosed that \"there is a risk that DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages.\" On this news, the price of Semler shares declined by $4.03 per share, from $42.92 per share on February 28, 2025, to close at $38.89 on March 3, 2025.\n \n\n For more information on the Semler investigation go to:\n \n https://bespc.com/cases/SMLR\n \n\n\n\n GoHealth, Inc. (NASDAQ:GOCO)\n \n\n\n On May 1, 2025, the U.S. Department of Justice (\"DOJ\") announced the filing of a False Claims Act co...